User Avatar

Charlie Lees

3y ago

All of this happened in IBD this month 👇

🧵 thread featuring:

• VEGA pub

• UPFs & Crohn's

• ADA descalation

• pharma news items

• an amazing 5-ASA story

• serological signatures & CD

• IFX biosimilar multi-switching

• a brilliant new website of IBD trials

1/14

User Avatar

Charlie Lees

3y ago

The IBD-EII website

All clinical trials in IBD on a timeline and brilliantly summarise by @Bealoquebea

Dive in and explore for your self - over 150 studies!

https://ibd-eii.com/

2/14

User Avatar

Charlie Lees

3y ago

The VEGA study was published

Combination guselkumab plus golimumab versus monotherapy of each agent in moderate active UC

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00427-7/fulltext

3/14

User Avatar

Charlie Lees

3y ago

Increased dose interval versus conventional dosing of adalimumab in Crohn's disease - the Ladi Trial

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00434-4/fulltext

4/14

User Avatar

Charlie Lees

3y ago

Epidemiology of IBD in Denmark

Evidence of a peak in incidence?

https://journals.lww.com/ajg/Abstract/9900/Has_the_Incidence_of_Inflammatory_Bowel_Disease.652.aspx

5/14

User Avatar

Charlie Lees

3y ago

Microbial enzymes discovered that inactivate 5-ASA and predict clinical non-response

Amazing multi-omics study with should translate to true precision medicine for UC

https://www.nature.com/articles/s41591-023-02217-7

6/14

User Avatar

Charlie Lees

3y ago

Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism

Intriguing study in mice suggests that daily administration of a specific probiotic could be beneficial

https://gut.bmj.com/content/early/2023/01/03/gutjnl-2021-326835

7/14

User Avatar

Charlie Lees

3y ago

Ultra-processed foods and the development of Crohn's disease

Further support of this association from a meta-analysis

https://www.cghjournal.org/article/S1542-3565(23)00071-X/fulltext#.Y95uzG2MWNY.twitter

8/14

User Avatar

Charlie Lees

3y ago

Multiple switching of infliximab biosimilars is safe and

effective in IBD

Our 3x switch data from Edinburgh IBD Unit should offer great reassurance here

https://onlinelibrary.wiley.com/doi/full/10.1002/ueg2.12357

9/14

User Avatar

Charlie Lees

3y ago

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Data from the GEM Study nested cohort

https://gut.bmj.com/content/early/2023/02/16/gutjnl-2022-328421

10/14

User Avatar

Charlie Lees

3y ago

Preclinical Serological Signatures are Associated with Complicated Crohn's Disease Phenotype at Diagnosis

Patients with complicated CD had higher levels of anti-microbial antibodies detected 6 years prior to diagnosis

https://www.cghjournal.org/article/S1542-3565(23)00100-3/pdf

11/14

User Avatar

Charlie Lees

3y ago

High perceived stress associated with disease flares in ulcerative colitis

https://www.cghjournal.org/article/S1542-3565(22)00721-2/fulltext

12/14

User Avatar

Charlie Lees

3y ago

Next week is the highlight of the year!

See you all in Copenhagen for ECCO.

Pop by and say hello, and if you arrive early you can let me know - i'm here already.

14/14